HistoSonics , maker of the Edison Histotripsy System and new histotripsy therapy platforms, announced the closing of an oversubscribed $102 million Series D financing. The...
HistoSonics, the manufacturer of the Edison System and novel histotripsy therapy platforms, announced the selection of the Innovative Devices Access Pathway (IDAP) pilot program, which...
HistoSonics, the manufacturer of the non-invasive Edison Histotripsy System, announced a patient from the University of Rochester Medical Center has received the world’s first...
HistoSonics, the developer of a non-invasive platform and novel sonic beam therapy called histotripsy, announced the first kidney patient has been treated using the...
HistoSonics, (www.histosonics.com), the developer and manufacturer of a completely non-invasive platform and proprietary sonic beam therapy, announced the publication of results from their prospective...
